β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial (vol 393, pg 1597, 2019)

被引：0
|
作者：
Villanueva, C.
Albillos, A.
Genesca, J.
机构：
来源：
LANCET | 2019年 / 393卷 / 10190期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2492 / 2492
页数：1
相关论文
共 50 条
  • [1] β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
    Villanueva, Candid
    Albillos, Agustin
    Genesca, Joan
    Garcia-Pagan, Joan C.
    Calleja, Jose L.
    Aracil, Carles
    Banares, Rafael
    Morillas, Rosa M.
    Poca, Maria
    Penas, Beatriz
    Augustin, Salvador
    Abraldes, Juan G.
    Alvarado, Edilmar
    Torres, Ferran
    Bosch, Jaume
    Torras, X.
    Cadafalch, J.
    Ardevol, A.
    Graupera, I.
    Pavel, O.
    Diez, X.
    Vargas, H.
    Pernas, J. C.
    Barcons, M.
    Gallego, A.
    Soriano, G.
    Gordillo, J.
    Santalo, M.
    Benito, S.
    Guarner, C.
    Tellez, L.
    Martinez, J.
    Rodriguez-Gandia, M. A.
    Mesonero, F.
    Martin, C.
    Millan, L.
    Pons, M.
    Torrens, M.
    Berzigotti, A.
    Seijoo, S.
    Hernandez-Gea, V.
    Turon, F.
    Llach, J.
    Bru, C.
    Escorsell, A.
    Llop, E.
    Perello, C.
    Minana, J. M.
    Zaragoza, N.
    Buenestado, J.
    LANCET, 2019, 393 (10181): : 1597 - 1608
  • [2] Preventing the decompensation of cirrhosis with β-blockers in patients with clinically significant portal hypertension. A multicenter double-blind placebo-controlled randomized clinical trial
    Villanueva, Candid
    Albillos, Agustin
    Genesca, Joan
    Carlos Garcia-Pagan, Juan
    Calleja, Jose L.
    Aracil, Carles
    Banares, Rafael
    Maria Morillas, Rosa
    Poca, Maria
    Penas, Beatriz
    Augustin, Salvador
    Abraldes, Juan G.
    Alvarado-Tapias, Edilmar
    Torres, Ferran
    Bosch, Jaime
    HEPATOLOGY, 2016, 64 (06) : 1121A - 1122A
  • [3] Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China
    Liu, Chuan
    Zhang, Liting
    Zhang, Shuairan
    Li, Xiaoguo
    Wong, Yu-Jun
    Liang, Xuan
    Wang, Yan
    Wu, Xiaofeng
    Gou, Wei
    Lv, Jiaojian
    Hu, Shengjuan
    Fu, Junliang
    Huang, Ju
    Ge, Guohong
    Huang, Mingxing
    Wang, Fang
    Zhang, Qingge
    Ren, Tao
    Meng, Zhongji
    Ding, Deping
    Zhuoga, Basang
    Zhuoga, Cidan
    Fan, Jian
    Dang, Dianjie
    Miao, Liang
    Song, Zhaomin
    Xiao, Xingguo
    Wu, Huili
    Jiang, Kai
    Liu, Tianyu
    Gao, Youfang
    Ma, Lan
    Fang, Tao
    Wang, Yuehua
    Zhang, Qianhua
    Zhu, Da
    Ji, Dong
    Cao, Zhujun
    Zeng, Qing-Lei
    Li, Jie
    Chen, Ping
    Wei, Yufang
    Tong, Zhaowei
    Hong, Zhongsi
    Liang, Xiao
    Li, Yiling
    Nan, Yuemin
    Qi, Xiaolong
    BMJ OPEN, 2024, 14 (07): : 1 - 5
  • [4] Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial
    Kemp, William
    Colman, John
    Thompson, Kenneth
    Madan, Anoop
    Vincent, Margaret
    Chin-Dusting, Jaye
    Kompa, Andrew
    Krum, Henry
    Roberts, Stuart
    LIVER INTERNATIONAL, 2009, 29 (03) : 427 - 433
  • [5] Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial
    Boxer, Adam L.
    Knopman, David S.
    Kaufer, Daniel I.
    Grossman, Murray
    Onyike, Chiadi
    Graf-Radford, Neill
    Mendez, Mario
    Kerwin, Diana
    Lerner, Alan
    Wu, Chuang-Kuo
    Koestler, Maly
    Shapira, Jill
    Sullivan, Kathryn
    Klepac, Kristen
    Lipowski, Kristine
    Ullah, Jerin
    Fields, Scott
    Kramer, Joel H.
    Merrilees, Jennifer
    Neuhaus, John
    Mesulam, M. Marsel
    Miller, Bruce L.
    LANCET NEUROLOGY, 2013, 12 (02): : 149 - 156
  • [6] Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial (vol 393, pg 1937, 2019)
    Heerspink, H. J. L.
    Parving, H-H
    Andress, D. L.
    LANCET, 2019, 393 (10184): : 1936 - 1936
  • [7] Mitoxantrone in progressive multiple sclerosis:: a placebo-controlled, double-blind, randomised, multicentre trial
    Hartung, HP
    Gonsette, R
    König, N
    Kwiecinski, H
    Guseo, A
    Morrissey, SP
    Krapf, H
    Zwingers, T
    LANCET, 2002, 360 (9350): : 2018 - 2025
  • [8] Prophylactic ibuprofen in premature infants:: a multicentre, randomised, double-blind, placebo-controlled trial
    Van Overmeire, B
    Allegaert, K
    Casaer, A
    Debauche, C
    Decaluwé, W
    Jespers, A
    Weyler, J
    Harrewijn, I
    Langhendries, JP
    LANCET, 2004, 364 (9449): : 1945 - 1949
  • [9] A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
    Shiina, Akihiro
    Shirayama, Yukihiko
    Niitsu, Tomihisa
    Hashimoto, Tasuku
    Yoshida, Taisuke
    Hasegawa, Tadashi
    Haraguchi, Tadashi
    Kanahara, Nobuhisa
    Shiraishi, Tetsuya
    Fujisaki, Mihisa
    Fukami, Goro
    Nakazato, Michiko
    Iyo, Masaomi
    Hashimoto, Kenji
    ANNALS OF GENERAL PSYCHIATRY, 2010, 9
  • [10] A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
    Akihiro Shiina
    Yukihiko Shirayama
    Tomihisa Niitsu
    Tasuku Hashimoto
    Taisuke Yoshida
    Tadashi Hasegawa
    Tadashi Haraguchi
    Nobuhisa Kanahara
    Tetsuya Shiraishi
    Mihisa Fujisaki
    Goro Fukami
    Michiko Nakazato
    Masaomi Iyo
    Kenji Hashimoto
    Annals of General Psychiatry, 9
12345